Paper| Volume 40, ISSUE 6, P817-821, December 15, 1985

Elevated plasmin-α2-antiplasmin complex levels in hereditary angioedema: Evidence for the in vivo efficiency of the intrinsic fibrinolytic system

      This paper is only available as a PDF. To read, Please Download here.


      The contact activation and fibrinolytic systems were assessed in 5 patients with hereditary angioedema (HAE). Reductions in F XII levels and increase in kallikrein-like activity in some patients indicated activation of the contact (intrinsic) system of coagulation. A great increase in plasmin-α2-antiplasmin complex in all subjects indicated that in this disease, there is a constantly ongoing fibrinolysis.
      Since C1-inhibitor, the deficient protein in HAE, is a poor inhibitor of the well-known extrinsic (tissue-type) plasminogen activator, but the major inhibitor of the contact activation system and a related Math Eq phenomenon termed intrinsic fibrinolysis, our data show that this fibrinolytic system is also sometimes operating efficiently Math Eq. Furthermore, the known clinical data on HAE are compatible with a role of intrinsic fibrinolysis in the pathophysiology of this disease.


      To read this article in full you will need to make a payment

      Purchase one-time access:

      Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
      One-time access price info
      • For academic or personal research use, select 'Academic and Personal'
      • For corporate R&D use, select 'Corporate R&D Professionals'


      Subscribe to Thrombosis Research
      Already a print subscriber? Claim online access
      Already an online subscriber? Sign in
      Institutional Access: Sign in to ScienceDirect


        • Fields T.
        • Ghebrehiwet B.
        • Kaplan A.P.
        Kinin formation in hereditary angioedema plasma: evidence against kinin derivation from C2 and in support of ‘spontaneous’ formation of bradykinin.
        J.Allerg.Clin.Immunol. 1983; 72: 54-60
        • Curd J.G.
        • Yelvington M.
        • Burridge N.
        Generation of bradykinin during incubation of hereditary angioedema plasma.
        Mol.Immunol. 1983; 19: 1365
        • Cullman W.
        • Kövary P.M.
        • Muller N.
        • Dick W.
        Complement, coagulation and fibrinolytic parameters in hereditary angioedema (HAE).
        Clin.Exp.Immunol. 1982; 49: 618-622
        • Gelfand J.A.
        • Sherins R.J.
        • Alling D.W.
        • Frank M.M.
        Treatment of hereditary angioedema with danazol.
        in: Reversal of clinical and biochemical abnormalities. N.Engl.J.Med.295. 1976: 1444-1448
        • Tankersley D.L.
        • Alving B.M.
        • Finlayson J.S.
        Activation of factor XII by dextran sulphate: the basis for an assay of factor XII.
        Blood. 1983; 62: 448-456
        • Friberger P.
        Chromogenic peptide substrates.
        in: Their use for the assay of factors in the fibrinolytic and the plasma kallikrein-kinin systems. Scand.J.Clin.Lab.Invest. suppl.1982: 162
        • Wiman B.
        • Nilsson T.
        A new simple method for determination of CI-esterase inhibitor activity in plasma.
        Clin.Chim.Acta. 1983; 128: 359-366
        • Nilsson T.
        • Back O.
        On the role of the C1-esterase inhibitor in cold urticaria.
        Acta Derm.Venereol. (Stockh). 1984; 64: 197-202
        • Wiman B.
        • Jacobsson L.
        • Andersson M.
        • Mellbring G.
        Determination of plasmin-α2-antiplasmin complex in plasma samples by means of a radioimmunoassay.
        Scand.J.Clin.Lab.Invest. 1983; 43: 27-33
        • Wiman B.
        • Mellbring G.
        • Ranby M.
        Plasminogen activator release during venous stasis and exercise as determined by a new specific assay.
        Clin.Chim.Acta. 1982; 127: 279-288
        • Bergsdorf N.
        • Nilsson T.
        • Wallen P.
        An enzyme linked immunosorbent assay for determination of tissue plasminogen activator applied to patients with thromboembolic disease.
        Thromb.Haemost. 1983; 50: 740-744
        • Mellbring G.
        • Dahlgren S.
        • Reiz S.
        • Wiman B.
        Fibrinolytic activity in plasma and deep vein thrombosis after major abdominal surgery.
        Thromb.Res. 1983; 32: 575-584
        • Ranby M.
        • Bergsdorf N.
        • Nilsson T.
        Enzymatic properties of one- and two-chain form of tissue plasminogen activator.
        Thromb.Res. 1982; 27: 175-183
        • Niewiarowski S.
        • Prou-Wartelle O.
        Röle du facteur contact (facteur Hageman) dans la fibrinolyse.
        Thromb.Diath. Haemorrh. 1959; 3: 593-603
        • Ogston D.
        • Ogston C.M.
        • Ratnoff O.D.
        • Forbes C.D.
        Studies on a complex mechanism for the activation of plasminogen by kaolin and chloroform: the participation of Hageman factor and additional cofactors.
        J.Clin.Invest. 1969; 48: 1786-1801
        • Kluft C.
        • Trumpi-Kalshoven M.M.
        • Jie A.F.H.
        • Veldhuyzen-Stolk E.C.
        Factor XII-dependent fibrinolysis: A double function of plasma kallikrein and the occurrence of a previously undescribed factor XII and kallikrein-dependent plasminogen proactivator.
        Thromb.Haemost. 1979; 41: 756-773
        • Saldeen T.
        Vasoactive peptides derived from degradation of fibrinogen and fibrin.
        Ann.N.Y.Acad.Sci. 1983; 408: 424-437